132 related articles for article (PubMed ID: 38442470)
1. Up-regulation of extracellular-matrix and inflammation related genes in oral squamous cell carcinoma.
Thakore VP; Patel KD; Vora HH; Patel PS; Jain NK
Arch Oral Biol; 2024 May; 161():105925. PubMed ID: 38442470
[TBL] [Abstract][Full Text] [Related]
2. An integrative analysis to enumerate candidate genes for clinical use in oral cancer.
Thakore VP; Patel KD; Bhadresha KP; Patel PS; Jain NK
J Cancer Res Ther; 2022 Dec; 18(Supplement):S182-S190. PubMed ID: 36510962
[TBL] [Abstract][Full Text] [Related]
3. Family with Sequence Similarity 72 (FAM72) - A prospective biomarker for poor prognosis in patients with oral squamous cell carcinoma.
Liu H; Huang Y; Chen Y; Tang Z; Huang M; Ming Y; Wang M; Chen W; Huang Z; Qing L; Wang Q; Jia B
Arch Oral Biol; 2023 Jul; 151():105695. PubMed ID: 37086493
[TBL] [Abstract][Full Text] [Related]
4. Role of hyaluronan mediated motility receptor gene in oral squamous cell carcinoma and clinical prognosis.
Tang Y; Xiao Y; Liao R
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Dec; 46(12):1315-1324. PubMed ID: 35232899
[TBL] [Abstract][Full Text] [Related]
5. A Novel Immune-Related Gene Signature to Identify the Tumor Microenvironment and Prognose Disease Among Patients With Oral Squamous Cell Carcinoma Patients Using ssGSEA: A Bioinformatics and Biological Validation Study.
Chen Y; Feng Y; Yan F; Zhao Y; Zhao H; Guo Y
Front Immunol; 2022; 13():922195. PubMed ID: 35935989
[TBL] [Abstract][Full Text] [Related]
6. Integration of transcriptomics and metabolomics reveals a novel gene signature guided by FN1 associated with immune response in oral squamous cell carcinoma tumorigenesis.
Peng Y; Yin D; Li X; Wang K; Li W; Huang Y; Liu X; Ren Z; Yang X; Zhang Z; Zhang S; Fan T
J Cancer Res Clin Oncol; 2023 Aug; 149(9):6097-6113. PubMed ID: 36656379
[TBL] [Abstract][Full Text] [Related]
7. Guanylate-binding protein 6 is a novel biomarker for tumorigenesis and prognosis in tongue squamous cell carcinoma.
Liu PF; Chen HC; Shu CW; Sie HC; Lee CH; Liou HH; Cheng JT; Tsai KW; Ger LP
Clin Oral Investig; 2020 Aug; 24(8):2673-2682. PubMed ID: 31707626
[TBL] [Abstract][Full Text] [Related]
8. Identification of the MMP family as therapeutic targets and prognostic biomarkers in the microenvironment of head and neck squamous cell carcinoma.
Liu M; Huang L; Liu Y; Yang S; Rao Y; Chen X; Nie M; Liu X
J Transl Med; 2023 Mar; 21(1):208. PubMed ID: 36941602
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of miRNA-196a and miRNA-196b correlates with Bryne's prognostic score in oral squamous cell carcinoma.
Singh K; Urs AB; Koner BC; Augustine J; Shrivastava R; Narayan B
Pathol Res Pract; 2024 Jan; 253():154954. PubMed ID: 38039741
[TBL] [Abstract][Full Text] [Related]
10. Genome-wide DNA methylation profile identified a unique set of differentially methylated immune genes in oral squamous cell carcinoma patients in India.
Basu B; Chakraborty J; Chandra A; Katarkar A; Baldevbhai JRK; Dhar Chowdhury D; Ray JG; Chaudhuri K; Chatterjee R
Clin Epigenetics; 2017; 9():13. PubMed ID: 28174608
[TBL] [Abstract][Full Text] [Related]
11. CXCL8, MMP12, and MMP13 are common biomarkers of periodontitis and oral squamous cell carcinoma.
Chen X; Lei H; Cheng Y; Fang S; Sun W; Zhang X; Jin Z
Oral Dis; 2024 Mar; 30(2):390-407. PubMed ID: 36321868
[TBL] [Abstract][Full Text] [Related]
12. NCBP2 and TFRC are novel prognostic biomarkers in oral squamous cell carcinoma.
Arora R; Haynes L; Kumar M; McNeil R; Ashkani J; Nakoneshny SC; Matthews TW; Chandarana S; Hart RD; Jones SJM; Dort JC; Itani D; Chanda A; Bose P
Cancer Gene Ther; 2023 May; 30(5):752-765. PubMed ID: 36635327
[TBL] [Abstract][Full Text] [Related]
13. A Five-mRNA Expression Signature to Predict Survival in Oral Squamous Cell Carcinoma by Integrated Bioinformatic Analyses.
Guo H; Li C; Su X; Huang X
Genet Test Mol Biomarkers; 2021 Aug; 25(8):517-527. PubMed ID: 34406843
[No Abstract] [Full Text] [Related]
14. HMG20A was identified as a key enhancer driver associated with DNA damage repair in oral squamous cell carcinomas.
Na L; Meijie Z; Wenjing Z; Bing Z; Yanhao D; Shanshan L; Yongle Q
BMC Oral Health; 2022 Nov; 22(1):473. PubMed ID: 36335317
[TBL] [Abstract][Full Text] [Related]
15. Parathyroid hormone-related protein serves as a prognostic indicator in oral squamous cell carcinoma.
Lv Z; Wu X; Cao W; Shen Z; Wang L; Xie F; Zhang J; Ji T; Yan M; Chen W
J Exp Clin Cancer Res; 2014 Dec; 33(1):100. PubMed ID: 25539663
[TBL] [Abstract][Full Text] [Related]
16. Identification of RNA-splicing factor Lsm12 as a novel tumor-associated gene and a potent biomarker in Oral Squamous Cell Carcinoma (OSCC).
Dong Y; Xue L; Zhang Y; Liu C; Zhang Y; Jiang N; Ma X; Chen F; Li L; Yu L; Liu X; Shao S; Guan S; Zhang J; Xiao Q; Li H; Dong A; Huang L; Shi C; Wang Y; Fu M; Lv N; Zhan Q
J Exp Clin Cancer Res; 2022 Apr; 41(1):150. PubMed ID: 35449073
[TBL] [Abstract][Full Text] [Related]
17. Prognostic model based on telomere-related genes predicts the risk of oral squamous cell carcinoma.
Yue K; Yao X
BMC Oral Health; 2023 Jul; 23(1):484. PubMed ID: 37452322
[TBL] [Abstract][Full Text] [Related]
18. Transcriptomic discovery of a theranostic signature (SERPINE1/MMP3/COL1A1/SPP1) for head and neck squamous cell carcinomas and identification of antrocinol as a candidate drug.
Shih ML; Lee JC; Cheng SY; Lawal B; Ho CL; Wu CC; Tzeng DTW; Chen JH; Wu ATH
Comput Biol Med; 2022 Nov; 150():106185. PubMed ID: 37859283
[TBL] [Abstract][Full Text] [Related]
19. Establishment and Analysis of Hypoxia-Related Model in Oral Squamous Cell Carcinoma.
Lu X; Liu X
J Healthc Eng; 2022; 2022():6602648. PubMed ID: 35432823
[TBL] [Abstract][Full Text] [Related]
20. The development of radioresistant oral squamous carcinoma cell lines and identification of radiotherapy-related biomarkers.
Huang J; Meng Q; Liu R; Li H; Li Y; Yang Z; Wang Y; Wanyan C; Yang X; Wei J
Clin Transl Oncol; 2023 Oct; 25(10):3006-3020. PubMed ID: 37029240
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
